An immuno-oncology company has filed for bankruptcy in Canada and is seeking a buyer. What is still unclear is whether the only BDC with exposure will be materially impacted or not. We assess the odds.
This post is for paying subscribers only
You might also like...
Horizon Technology Finance: IQ 2023 Credit Highlights
10 min read
IMV Corp: Downgraded to CCR 5
1 min read
Evelo Biosciences Inc.: Added To Underperformers List